PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL DOSAGE FORM UNDERSTANDING (E) -4- (2- (AMINOMETHIL) -3-FLUOROALYLOXY) -N-TERC-BUTYLBENZAMIDE, PROCESS FOR ITS PREPARATION, METHODS FOR TREATMENT AND ITS USES
JÖRG RIPPMANN,KAZUTOSHI YOKOYAMA,KENJI EGUSA,NGAI HANG VICTOR CHONG,REMKO ALEXANDER BAKKER,TAKUMA KATAYAMA
申请号：
BR112019022142
公开号：
BR112019022142A2
申请日:
2018.05.30
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
the present invention relates to pharmaceutical compositions comprising (e) -4- (2- (aminomethyl) -3-fluoroalyloxy) -n-tert-butylbenzamide with the following chemical structure or a pharmaceutically acceptable salt thereof as an active pharmaceutical ingredient, particularly pharmaceutical compositions comprising (e) -4- (2- (aminomethyl) -3-fluoroalyloxy) -n-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, their preparation, their use and methods for therapeutic treatment.a presente invenção refere-se a composições farmacêuticas compreendendo (e)-4-(2-(aminometil)-3-fluoroalilóxi)-n-terc-butilbenzamida com a seguinte estrutura química ou um sal farmaceuticamente aceitável da mesma como ingrediente farmacêutico ativo, particularmente composições farmacêuticas compreendendo cloridrato de (e)-4-(2-(aminometil)-3-fluoroalilóxi)-n-terc-butilbenzamida, a formas de dosagem farmacêuticas, sua preparação, seu uso e métodos para tratamento terapêutico.
